MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions Retained Earnings 2011-2026 | BLFS
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -335 M | -315 M | -247 M | -107 M | - | -100 M | -71 M | -74 M | -71.2 M | - | -60.1 M | -56.9 M | -55.8 M | -54.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -54.2 M | -335 M | -129 M |
Quarterly Retained Earnings BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -351 M | -351 M | -336 M | -335 M | -348 M | -346 M | -325 M | -315 M | -300 M | -271 M | -261 M | -247 M | -198 M | -187 M | -115 M | -105 M | -90.5 M | -90.6 M | -98.5 M | -97.4 M | -97.4 M | -97.4 M | -97.4 M | -100 M | -100 M | -100 M | -100 M | -98.4 M | -71 M | -71 M | -71 M | -74 M | -74 M | -74 M | -74 M | -71.2 M | -71.2 M | -71.2 M | -71.2 M | -64.3 M | -64.3 M | -64.3 M | -64.3 M | -60.1 M | -60.1 M | -60.1 M | -60.1 M | -56.9 M | -56.9 M | -56.9 M | -56.9 M | -55.8 M | -55.8 M | -55.8 M | -55.8 M | -54.2 M | -54.2 M | -54.2 M | -54.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -54.2 M | -351 M | -127 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 202.09 | -0.31 % | $ 58.1 B |  USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
Baxter International
BAX
|
14.9 B | $ 20.07 | -4.72 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
690 M | $ 151.18 | -1.18 % | $ 3.69 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 8.77 | 1.15 % | $ 181 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Repro Med Systems
KRMD
|
-23.3 M | $ 5.87 | 3.89 % | $ 268 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
-250 M | $ 8.45 | 6.56 % | $ 170 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 80.71 | 0.72 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-402 M | $ 37.21 | -10.25 % | $ 1.75 B | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 130.93 | -5.75 % | $ 6.98 B | USA |
 |
electroCore
ECOR
|
-165 M | $ 6.35 | 12.79 % | $ 35 K | USA |
 |
Merit Medical Systems
MMSI
|
696 M | $ 83.15 | -3.74 % | $ 4.84 B | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.16 | 3.04 % | $ 415 M | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 83.29 | -0.19 % | $ 16.6 B | USA |
 |
LeMaitre Vascular
LMAT
|
145 M | $ 84.2 | -0.94 % | $ 1.89 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 82.57 | 0.66 % | $ 4.16 B | USA |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.62 | -2.13 % | $ 26.3 M | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 111.12 | -1.6 % | $ 5.38 B | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
-759 M | $ 168.23 | -6.24 % | $ 5.25 B | USA |
 |
OraSure Technologies
OSUR
|
-103 M | $ 2.7 | 2.66 % | $ 201 M | USA |
 |
Intuitive Surgical
ISRG
|
6.8 B | $ 572.2 | -2.39 % | $ 203 B | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 2.13 | 2.15 % | $ 21.7 M |  Israel |
 |
Nephros
NEPH
|
-144 M | $ 4.58 | -4.78 % | $ 47.6 M | USA |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.29 | -1.09 % | $ 23.1 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
-487 M | $ 23.47 | -0.68 % | $ 4.04 B | USA |
 |
Predictive Oncology
POAI
|
-180 M | $ 6.84 | 0.22 % | $ 37.3 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 43.19 | 3.46 % | $ 142 M | USA |
 |
Pulse Biosciences
PLSE
|
-337 M | $ 14.47 | -0.17 % | $ 695 M | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 169.22 | 1.44 % | $ 9.43 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 257.08 | 1.8 % | $ 37.6 B | USA |
 |
STERIS plc
STE
|
2.48 B | $ 260.03 | 1.31 % | $ 25.6 B | USA |
 |
Stereotaxis
STXS
|
-538 M | $ 2.56 | 1.79 % | $ 207 M | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.76 | -1.91 % | $ 22.8 M | USA |
 |
STAAR Surgical Company
STAA
|
-67.6 M | $ 22.06 | -0.26 % | $ 1.08 B | USA |
 |
Teleflex Incorporated
TFX
|
4.12 B | $ 109.07 | -3.33 % | $ 5.11 B | USA |
 |
Utah Medical Products
UTMD
|
138 M | $ 60.1 | 0.33 % | $ 218 M | USA |
 |
West Pharmaceutical Services
WST
|
3.96 B | $ 272.1 | -1.18 % | $ 19.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-835 M | $ 12.44 | -2.7 % | $ 2.53 B | USA |